NCT05572307

Brief Summary

Single-celled sequencing for evaluating differences in gene expression patterns in different cell types of the dynamics of a means of this research as a starting point, to study the postoperative delirium and chronic pain at the cellular level changes the contents of a cell, reveal its occurrence and development of the role of gene regulation, find targets and biomarkers, and to provide new ideas for its pathogenesis, To provide theoretical basis support for its prevention, clinical diagnosis and treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 7, 2022

Completed
23 days until next milestone

Study Start

First participant enrolled

October 30, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

March 8, 2023

Status Verified

September 1, 2022

Enrollment Period

1 year

First QC Date

September 29, 2022

Last Update Submit

March 7, 2023

Conditions

Outcome Measures

Primary Outcomes (6)

  • Difference of single cell sequencing before and after surgery

    Leukocytes were isolated from peripheral blood and then sorted for subsequent single-cell sequencing analysis. Unbiased, high-throughput and high-resolution transcriptome analysis of single cells can reveal the gene structure and gene expression status of single cells, reflect the heterogeneity between cells, classify and analyze them, and carry out personalized research

    1 day before surgery,1 day after surgery

  • 3-minute Diagnostic Interview for CAM (3D-CAM)

    Postoperative delirium was assessed by 3-minute Diagnostic Interview for confusion assessment method (CAM).

    Consecutive 7 days after the surgery

  • Visual analogue scale(VAS)

    A moving scale measuring about 10cm in length was used, with 10 scales on one side and "0" and "10" ends, respectively, with 0 indicating no pain and 10 indicating the most severe pain that could not be endured.

    3 months after the surgery

  • Short form McGill pain questionnaire(SF-MPQ)

    SF-MPQ is composed of sensory and emotional descriptors of pain, current pain intensity and visual analogue scale.

    3 months after the surgery

  • Leeds Assessment of Neuropathic Symptoms and Signs(LANSS)

    Make the needle perpendicular to the patient's skin, and apply different pressure on the skin to determine whether the patient has touch-induced pain.

    3 months after the surgery

  • Pain catastrophizing scale(PCS)

    PCS is defined as a belief system, a coping strategy and an evaluation process when experiencing and feeling pain.

    3 months after the surgery

Study Arms (4)

POD group

According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group

non-POD group

According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group

CPSP group

Patients were divided into CPSP group and non-CPSP group according to the occurrence of postoperative chronic pain

non-CSP group

Patients were divided into CPSP group and non-CPSP group according to the occurrence of postoperative chronic pain

Eligibility Criteria

Age65 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing elective total knee replacement.

You may qualify if:

  • Age ≥65 years old, regardless of gender.
  • total knee arthroplasty for the first time.
  • The ASA classification is I-Ⅲ.

You may not qualify if:

  • severe neurological or psychiatric disorders
  • drug and alcohol abuse
  • patients on antidepressants
  • failure and decompensation of vital organs
  • chronic pain from previous surgery or trauma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xuzhou Central Hospital

Xuzhou, Jiangsu, 221000, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Nucleated cells from peripheral blood were extracted and frozen.These cells are destroyed after single-cell sequencing.

MeSH Terms

Conditions

Emergence DeliriumPain, Postoperative

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental DisordersPain

Study Officials

  • Yangzi Zhu, Doctor

    Xuzhou Central Hospital

    PRINCIPAL INVESTIGATOR
  • Liwei Wang, Doctor

    Xuzhou Central Hospital

    STUDY DIRECTOR
  • Junli Cao, Doctor

    Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University

    STUDY DIRECTOR
  • Daqing Ma, Doctor

    Imperial College London, Chelsea and Westminster Hospital

    STUDY CHAIR

Central Study Contacts

Yangzi Zhu, Doctor

CONTACT

Liwei Wang, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2022

First Posted

October 7, 2022

Study Start

October 30, 2022

Primary Completion

October 30, 2023

Study Completion

December 31, 2023

Last Updated

March 8, 2023

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations